India takes bold step to eliminate animal testing in drug trials


In a groundbreaking step towards revolutionizing drug development, the Government of India has recently passed a momentous amendment to the New Drugs and Clinical Trial Rules (2023). This landmark amendment paves the way for the elimination of animal testing in drug trials, ushering in a new era of ethical and innovative research practices.

Emphasis on Reduction, Refinement, and Replacement of Animal Testing

The amendment places paramount importance on the reduction, refinement, and replacement of animal testing methods. It encourages researchers to explore alternative approaches that rely on cutting-edge technologies, such as in silico (computer simulation) models and in vitro (test tube) studies. By minimizing animal involvement, India aims to enhance the safety and efficiency of drug development processes.

Prioritizing Ethical Treatment and Animal Welfare

Under this amendment, researchers are mandated to uphold the ethical treatment of animals during clinical trials. Stringent guidelines require researchers to provide a comprehensive justification for the use of animals, outlining the potential benefits of the research and the measures taken to minimize animal suffering. By adhering to internationally accepted standards on animal welfare, India sets a benchmark for compassionate and responsible drug development practices.

Technological Alternatives Driving Progress

To ensure the success of animal-free clinical trials, various innovative technologies are being embraced. These include the utilization of human cells or stem cells to create organoids or mini-organs that mimic specific organs in the body. Additionally, the development of “organ-on-a-chip” technology, comprising AA-battery-sized chips lined with human cells and microchannels, enables the replication of blood flow and essential physiological processes. Another promising advancement involves the use of 3D bioprinters, capable of “printing” biological tissues using human cells and fluids as “bio-ink.” These technologies not only enhance scientific understanding but also offer the potential for personalized drug testing.

SP LOGO

Dr. Kirti Sisodhia

Content Writer

CATEGORIES Business Agriculture Technology Environment Health Education

SHARE YOUR STORY

info@seepositive.in

SEND FEEDBACK

contact@seepositive.in

FOLLOW US

GET OUR POSITIVE STORIES

Uplifting stories, positive impact and updates delivered straight into your inbox.

You have been successfully Subscribed! Ops! Something went wrong, please try again.
CATEGORIES Business Agriculture Technology Environment Health Education

SHARE YOUR STORY

info@seepositive.in

SEND FEEDBACK

contact@seepositive.in

FOLLOW US

GET OUR POSITIVE STORIES

Uplifting stories, positive impact and updates delivered straight into your inbox.

You have been successfully Subscribed! Ops! Something went wrong, please try again.